"It’s cold and flu season. Feel better, faster with convenient walk-in family and urgent care. Open 7 days a week with extended hours - no appointment needed. Most insurance plans accepted."

During the past decade, Re:Cognition Health conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Re:Cognition Health" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Alzheon Inc." with 1 trials sponsored, "Biogen" with 1 trials sponsored, "Cassava Sciences, Inc." with 1 trials sponsored and "Global Alzheimer's Platform Foundation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Re:Cognition Health" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Re:Cognition Health" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease (AD)" (1 trials), "Alzheimers Disease" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Re:Cognition Health" in a lesser frequency.

Most popular intervention types in "Re:Cognition Health" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "BIIB092" (1 trials), "Donanemab" (1 trials), "Experimental: ALZ-801" (1 trials) and "GV-971" (1 trials). Other intervention names were less common.

The vast majority of trials in "Re:Cognition Health" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Re:Cognition Health". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Re:Cognition Health, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Re:Cognition Health, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".